Overview

Effect of Rozerem on the Perception of GERD Symptoms in Patients With Chronic Insomnia.

Status:
Unknown status
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
To determine if administration of Rozerem in comparison to a placebo reduces or eliminates gastroesophageal reflux disease(GERD) symptoms in individuals with both GERD and chronic insomnia.
Phase:
Phase 3
Details
Lead Sponsor:
Southern Arizona VA Health Care System